Showing 1 - 11 results of 11 for search 'M Hallek', query time: 0.04s
Refine Results
-
1
-
2
P681: EUROFLOW STANDARDIZATION TECHNIQUE AND NORMALIZATION PROCEDURES IN LONGITUDINAL FLOW CYTOMETRIC EXPRESSION ANALYSIS OF CD20 IN CLL PATIENTS RECEIVING ANTI-CD20 DIRECTED THERA... by P. J. Walter, A. Schilhabel, P. Cramer, J. von Tresckow, S. Kohlscheen, K. Fischer, B. Eichhorst, S. Böttcher, M. Brüggemann, M. Kneba, M. Hallek, M. Ritgen
Published 2022-06-01
Article -
3
S148: VENETOCLAX-OBINUTUZUMAB FOR PREVIOUSLY UNTREATED CHRONIC LYMPHOCYTIC LEUKEMIA: 5-YEAR RESULTS OF THE RANDOMIZED CLL14 STUDY by O. Al-Sawaf, C. Zhang, S. Robrecht, A. Kotak, N. Chang, A.-M. Fink, E. Tausch, C. Schneider, M. Ritgen, K.-A. Kreuzer, B. Chyla, B. Eichhorst, Y. Jiang, S. Stilgenbauer, M. Hallek, K. Fischer
Published 2022-06-01
Article -
4
P1184: PHASE I TRIAL OF MB-CART2019.1 IN PATIENTES WITH RELAPSED OR REFRATORY B-CELL NON-HODGKIN LYMPHOMA: 2 YEAR FOLLOW-UP REPORT by P. Borchmann, A. Lohneis, P. Gödel, H. Balke-Want, C. Schmid, F. Ayuk, S. Holtkamp, L. Hanssens, G. Zadoyan, B. Friedrichs, M. Assenmacher, I. Bürger, D. Schneider, T. Overstijns, C. Scheid, U. Holtick, S. Miltenyi, M. Hallek
Published 2022-06-01
Article -
5
P1249: INHIBITION OF THE PENTOSE-PHOSPHATE-PATHWAY (PPP) MEDIATES MACROPHAGE REPROGRAMMING FROM SUPPORTIVE BYSTANDER FUNCTION TOWARDS ANTIBODY-DEPENDENT LYMPHOMA CELL CLEARANCE AND... by A. Beielstein, E. Izquierdo-Alvarez, N. Nickel, S. Blakemore, D. Vorholt, S. Chawan, H.-H. Bartel, J. Wiederstein, R. Linke, R. Brinker, M. Michalik, C. R. Costa Picossi, A. Villasenor, C. Barbas, M. Krüger, M. Hallek, C. Pallasch
Published 2022-06-01
Article -
6
P641: RETREATMENT WITH VENETOCLAX AFTER VENETOCLAX, OBINUTUZUMAB +/- IBRUTINIB: POOLED ANALYSIS OF 13 PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) TREATED IN GCLLSG TRIALS by P. Cramer, M. Fürstenau, A. Giza, S. Robrecht, E. Tausch, C. Schneider, C.-M. Wendtner, M. Hoechstetter, J. Schetelig, S. Böttcher, P. Dreger, A.-M. Fink, P. Langerbeins, O. Al-Sawaf, K. Fischer, S. Stilgenbauer, B. Eichhorst, M. Hallek
Published 2022-06-01
Article -
7
S146: VENETOCLAX IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA WITH 17P DELETION: 6-YEAR FOLLOW-UP AND GENOMIC ANALYSES IN A PIVOTAL PHASE 2 TRIAL by S. Stilgenbauer, E. Tausch, A. W. Roberts, M. S. Davids, B. Eichhorst, M. Hallek, P. Hillmen, C. Schneider, S. Böttcher, R. Popovic, M. T. Ghanim, M. Moran, W. J. Sinai, X. Wang, N. Mukherjee, B. Chyla, W. G. Wierda, J. F. Seymour
Published 2022-06-01
Article -
8
P652: MEASURING MINIMAL RESIDUAL DISEASE BEYOND 10-4 THROUGH IGHV LEADER-BASED NEXT GENERATION SEQUENCING IMPROVES PROGNOSTIC STRATIFICATION IN CHRONIC LYMPHOCYTIC LEUKEMIA by P. Hengeveld, M. van der Klift, P. M. Kolijn, F. Davi, F. Kavelaars, E. de Jonge, S. Robrecht, J. Assmann, L. van der Straten, M. Ritgen, P. Westerweel, K. Fischer, V. Goede, M. Hallek, M.-D. Levin, A. Langerak
Published 2022-06-01
Article -
9
S143: TRANSCRIPTOMIC CHARACTERIZATION OF MRD RESPONSE AND NON-RESPONSE IN PATIENTS TREATED WITH FIXED-DURATION VENETOCLAX-OBINUTUZUMAB by O. Al-Sawaf, H. Y. Jin, C. Zhang, Y. Choi, S. Balasubramanian, S. Robrecht, A. Kotak, N. Chang, A.-M. Fink, E. Tausch, C. Schneider, M. Ritgen, K.-A. Kreuzer, B. Chyla, J. Paulson, B. Eichhorst, S. Stilgenbauer, Y. Jiang, M. Hallek, K. Fischer
Published 2022-06-01
Article -
10
Rekomendatsiipo khronicheskomu limfoleykozu by E A Nikitin, M Hallek, V V Baykov, B A Bakirov, S S Bessmel'tsev, T P Zagoskina, A M Kovrigina, T S Konstantinova, Yu A Krivolapov, S A Lugovskaya, A E Matsionis, T N Obukhova, E A Osmanov, T I Pospelova, O S Samoylova, E A Stadnik, N N Tupitsyn, Yu V Shatokhin, I V Poddubnaya
Published 2012-12-01
Article -
11
Actionable perturbations of damage responses by TCL1/ATM and epigenetic lesions form the basis of T-PLL by A. Schrader, G. Crispatzu, S. Oberbeck, P. Mayer, S. Pützer, J. von Jan, E. Vasyutina, K. Warner, N. Weit, N. Pflug, T. Braun, E. I. Andersson, B. Yadav, A. Riabinska, B. Maurer, M. S. Ventura Ferreira, F. Beier, J. Altmüller, M. Lanasa, C. D. Herling, T. Haferlach, S. Stilgenbauer, G. Hopfinger, M. Peifer, T. H. Brümmendorf, P. Nürnberg, K. S. J. Elenitoba-Johnson, S. Zha, M. Hallek, R. Moriggl, H. C. Reinhardt, M.-H. Stern, S. Mustjoki, S. Newrzela, P. Frommolt, M. Herling
Published 2018-02-01
Article